Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 11 | 2022 | 61 | 7.580 |
Why?
|
| Atrial Fibrillation | 14 | 2023 | 110 | 7.320 |
Why?
|
| Pulmonary Veins | 7 | 2023 | 17 | 5.020 |
Why?
|
| Atrial Appendage | 4 | 2022 | 26 | 2.290 |
Why?
|
| Cryosurgery | 3 | 2020 | 17 | 2.070 |
Why?
|
| Tachycardia, Ventricular | 2 | 2022 | 20 | 1.540 |
Why?
|
| Cardiac Resynchronization Therapy | 4 | 2022 | 7 | 1.100 |
Why?
|
| Treatment Outcome | 13 | 2022 | 3285 | 0.980 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2022 | 33 | 0.950 |
Why?
|
| Heart Failure | 3 | 2022 | 148 | 0.910 |
Why?
|
| Radiography, Interventional | 2 | 2020 | 18 | 0.840 |
Why?
|
| Bundle of His | 6 | 2022 | 10 | 0.810 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 25 | 0.790 |
Why?
|
| Electrocardiography | 3 | 2022 | 95 | 0.780 |
Why?
|
| Pacemaker, Artificial | 4 | 2022 | 18 | 0.730 |
Why?
|
| Radiation Exposure | 2 | 2020 | 7 | 0.720 |
Why?
|
| Vectorcardiography | 1 | 2020 | 1 | 0.720 |
Why?
|
| Radiation Dosage | 2 | 2020 | 38 | 0.720 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 5 | 0.710 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 7 | 0.710 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 20 | 0.710 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 7 | 0.710 |
Why?
|
| Prone Position | 1 | 2020 | 30 | 0.710 |
Why?
|
| Humans | 23 | 2023 | 26260 | 0.670 |
Why?
|
| Antiviral Agents | 1 | 2020 | 70 | 0.670 |
Why?
|
| Recurrence | 4 | 2022 | 288 | 0.670 |
Why?
|
| Body Surface Potential Mapping | 1 | 2019 | 3 | 0.670 |
Why?
|
| Hepatic Veins | 1 | 2019 | 10 | 0.650 |
Why?
|
| Middle Aged | 12 | 2022 | 8541 | 0.640 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 18 | 0.630 |
Why?
|
| Cardiac Catheterization | 1 | 2019 | 60 | 0.620 |
Why?
|
| Cardiac Pacing, Artificial | 5 | 2022 | 17 | 0.610 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 193 | 0.610 |
Why?
|
| Heart Ventricles | 4 | 2022 | 90 | 0.600 |
Why?
|
| Feasibility Studies | 5 | 2022 | 199 | 0.600 |
Why?
|
| Swine | 3 | 2022 | 70 | 0.570 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2022 | 68 | 0.560 |
Why?
|
| Fluoroscopy | 4 | 2020 | 40 | 0.550 |
Why?
|
| Exercise | 1 | 2020 | 416 | 0.540 |
Why?
|
| Equipment Design | 3 | 2022 | 134 | 0.530 |
Why?
|
| Female | 13 | 2022 | 14520 | 0.510 |
Why?
|
| Time Factors | 6 | 2021 | 1347 | 0.500 |
Why?
|
| Stroke Volume | 4 | 2022 | 42 | 0.480 |
Why?
|
| Heart Rate | 4 | 2020 | 105 | 0.420 |
Why?
|
| Male | 11 | 2022 | 14168 | 0.410 |
Why?
|
| Aged | 9 | 2022 | 8595 | 0.380 |
Why?
|
| Lasers | 2 | 2022 | 15 | 0.380 |
Why?
|
| Therapeutic Irrigation | 2 | 2022 | 54 | 0.380 |
Why?
|
| Retrospective Studies | 6 | 2022 | 3283 | 0.370 |
Why?
|
| Risk Factors | 4 | 2020 | 2221 | 0.370 |
Why?
|
| Action Potentials | 3 | 2020 | 78 | 0.360 |
Why?
|
| Animals | 3 | 2022 | 3551 | 0.330 |
Why?
|
| Risk Assessment | 2 | 2020 | 592 | 0.290 |
Why?
|
| Prospective Studies | 3 | 2020 | 1665 | 0.270 |
Why?
|
| Registries | 3 | 2021 | 170 | 0.260 |
Why?
|
| Exercise Test | 2 | 2020 | 71 | 0.220 |
Why?
|
| Echocardiography | 1 | 2023 | 92 | 0.210 |
Why?
|
| Observational Studies as Topic | 1 | 2022 | 16 | 0.200 |
Why?
|
| Electrocoagulation | 1 | 2022 | 12 | 0.200 |
Why?
|
| Endocardium | 1 | 2022 | 1 | 0.200 |
Why?
|
| Heart | 1 | 2022 | 54 | 0.190 |
Why?
|
| Bradycardia | 1 | 2021 | 22 | 0.190 |
Why?
|
| Thermography | 1 | 2021 | 11 | 0.190 |
Why?
|
| Temperature | 1 | 2021 | 56 | 0.190 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 4594 | 0.180 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 12 | 0.180 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 15 | 0.180 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 10 | 0.180 |
Why?
|
| Patient Positioning | 1 | 2020 | 38 | 0.180 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 74 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 303 | 0.170 |
Why?
|
| Alcoholism | 1 | 2020 | 72 | 0.170 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 60 | 0.170 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 122 | 0.170 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 47 | 0.170 |
Why?
|
| Treatment Failure | 1 | 2020 | 158 | 0.160 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 98 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 343 | 0.160 |
Why?
|
| Atrial Function, Left | 1 | 2019 | 1 | 0.160 |
Why?
|
| Punctures | 1 | 2019 | 8 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 82 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2020 | 397 | 0.160 |
Why?
|
| Adult | 2 | 2021 | 7516 | 0.160 |
Why?
|
| Hypertension | 1 | 2020 | 230 | 0.150 |
Why?
|
| Stroke | 1 | 2021 | 255 | 0.150 |
Why?
|
| Age Factors | 1 | 2020 | 744 | 0.150 |
Why?
|
| Obesity | 1 | 2020 | 299 | 0.140 |
Why?
|
| Prosthesis Design | 1 | 2019 | 492 | 0.140 |
Why?
|
| Reoperation | 1 | 2020 | 888 | 0.130 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 34 | 0.090 |
Why?
|
| Chicago | 2 | 2020 | 857 | 0.070 |
Why?
|
| Bundle-Branch Block | 1 | 2022 | 4 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2022 | 10 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2021 | 76 | 0.050 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2020 | 4 | 0.050 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 4 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2021 | 84 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 40 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 163 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 285 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 2 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2019 | 7 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 32 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 709 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 676 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 422 | 0.040 |
Why?
|